ArticleArthritis research & therapy2012

Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis.

Robert D Inman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.